A detailed history of Engineers Gate Manager LP transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 11,389 shares of RPTX stock, worth $15,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,389
Previous 14,763 22.85%
Holding current value
$15,375
Previous $48,000 18.75%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.75 - $3.99 $9,278 - $13,462
-3,374 Reduced 22.85%
11,389 $39,000
Q2 2024

Aug 14, 2024

BUY
$3.02 - $4.7 $44,584 - $69,386
14,763 New
14,763 $48,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $56.6M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.